Darsana Capital Partners LP Acquires 1,000,000 Shares of Sotera Health Company $SHC

Darsana Capital Partners LP increased its holdings in shares of Sotera Health Company (NASDAQ:SHC) by 3.8% during the second quarter, Holdings Channel.com reports. The fund owned 27,000,000 shares of the company’s stock after purchasing an additional 1,000,000 shares during the quarter. Sotera Health accounts for about 2.2% of Darsana Capital Partners LP’s holdings, making the stock its 4th biggest position. Darsana Capital Partners LP owned 0.09% of Sotera Health worth $479,250,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Empowered Funds LLC raised its stake in Sotera Health by 11.1% in the first quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock valued at $332,000 after purchasing an additional 2,845 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Sotera Health by 14.5% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company’s stock worth $3,999,000 after buying an additional 43,471 shares in the last quarter. Acadian Asset Management LLC increased its holdings in Sotera Health by 125.5% in the 1st quarter. Acadian Asset Management LLC now owns 25,192 shares of the company’s stock valued at $293,000 after buying an additional 14,018 shares during the period. Creative Planning raised its position in shares of Sotera Health by 15.3% in the 2nd quarter. Creative Planning now owns 20,186 shares of the company’s stock valued at $224,000 after buying an additional 2,673 shares in the last quarter. Finally, Invesco Ltd. boosted its position in shares of Sotera Health by 4.2% during the 2nd quarter. Invesco Ltd. now owns 319,156 shares of the company’s stock worth $3,549,000 after acquiring an additional 12,758 shares in the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

Sotera Health Stock Performance

Shares of Sotera Health stock opened at $18.33 on Thursday. The company’s 50 day moving average price is $18.41 and its two-hundred day moving average price is $16.49. The firm has a market capitalization of $5.23 billion, a P/E ratio of 32.16 and a beta of 1.77. Sotera Health Company has a fifty-two week low of $13.09 and a fifty-two week high of $19.85. The company has a debt-to-equity ratio of 3.33, a current ratio of 2.80 and a quick ratio of 2.55.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.02. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The company had revenue of $321.38 million during the quarter, compared to analysts’ expectations of $309.70 million. During the same period in the prior year, the company earned $0.20 EPS. Sotera Health’s revenue was up 9.2% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, equities analysts forecast that Sotera Health Company will post 0.86 earnings per share for the current fiscal year.

Insider Transactions at Sotera Health

In other Sotera Health news, Chairman Michael B. Jr. Petras sold 850,000 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $18.50, for a total value of $15,725,000.00. Following the completion of the transaction, the chairman directly owned 3,969,393 shares in the company, valued at approximately $73,433,770.50. This trade represents a 17.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Michael P. Rutz sold 150,000 shares of Sotera Health stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $18.84, for a total value of $2,826,000.00. Following the sale, the insider directly owned 334,279 shares in the company, valued at $6,297,816.36. The trade was a 30.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 1,294,515 shares of company stock valued at $23,999,528. Insiders own 15.36% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have commented on SHC. Wall Street Zen upgraded shares of Sotera Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 29th. Piper Sandler reiterated an “overweight” rating and issued a $25.00 price target on shares of Sotera Health in a research note on Tuesday. Barclays boosted their price target on Sotera Health from $19.00 to $22.00 and gave the stock an “overweight” rating in a report on Friday, August 7th. JPMorgan Chase & Co. raised their price objective on Sotera Health from $16.00 to $18.00 and gave the company a “neutral” rating in a research note on Friday, August 7th. Finally, Citigroup lifted their target price on Sotera Health from $23.00 to $25.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Eight analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $21.50.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.